Janssen targeted in myeloma patent row

12-04-2016

Janssen targeted in myeloma patent row

Feng Yu / Shutterstock.com

Biotechnology company MorphoSys has sued both Janssen Biotech and Genmab in a patent infringement lawsuit centring on a drug used to treat myeloma, a form of cancer.


MorphoSys, Janssen Biotech, Genmab, US District Court for the District of Delaware, patent infringement, patent, biotech, Darzalex, myeloma, daratumumab

LSIPR